Cancer-stricken woman, 68, has months to live after NHS doctors missed a 3cm tumour clearly visible on scan - and failed to check her properly for two years
Anne Shaw, 68, had been treated successfully for breast and ovarian cancer, which put her at higher risk of having cancer again. (Source: the Mail online | Health)
Source: the Mail online | Health - February 26, 2024 Category: Consumer Health News Source Type: news
The Unique Hell of Getting Cancer as a Young Adult
When I got diagnosed with Stage 3b Hodgkin Lymphoma at age 32, it was almost impossible to process. Without a family history or lifestyle risk factors that put cancer on my radar, I stared at the emergency room doctor in utter disbelief when he said the CT scan of my swollen lymph node showed what appeared to be cancer—and lots of it. A few days away from a bucket list trip to Japan, I’d only gone to the emergency room because the antibiotics CityMD prescribed to me when I was sick weren’t working.I didn’t want to be sick in a foreign country. So when the doctor told me of my diagnosis, the on...
Source: TIME: Health - February 23, 2024 Category: Consumer Health News Authors: Maria Yagoda Tags: Uncategorized freelance Source Type: news
Mayo Clinic Minute: Health disparities in gynecologic cancers
Each year, thousands of women are diagnosed with gynecologic cancers in the U.S. While cervical, ovarian and uterine cancer affects all races, Black women are often diagnosed at later stages and are more likely to die from these diseases. Dr. Kristina Butler, a Mayo Clinic gynecologic oncologist, discusses health disparities and prevention. Watch: The Mayo Clinic Minute https://youtu.be/qnJg1eEtcN0 Journalists: Broadcast-quality video (1:05) is in the downloads at the end of this post. Please courtesy: "Mayo… (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - February 15, 2024 Category: Databases & Libraries Source Type: news
Ovarian cancer could soon be detected early thanks to simple urine test
New research by Professor Joseph Reiner and his colleagues at Virginia Commonwealth University in the United States has shown promise for a urine-based test for ovarian cancer (Source: Daily Express - Health)
Source: Daily Express - Health - February 10, 2024 Category: Consumer Health News Source Type: news
New Hope For Aggressive Ovarian Cancer
mRNA injections could reduce aggressive ovarian tumors by rescuing an often mutated gene in high-grade serous ovarian patients, according to a preclinical study. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - February 9, 2024 Category: Pharmaceuticals Authors: William A. Haseltine, Contributor Tags: Healthcare /healthcare Innovation /innovation business pharma & standard Source Type: news
Nonprofit Teams With Firefighter Union for Asbestos Ban Campaign
The Asbestos Disease Awareness Organization is teaming with the International Association of Fire Fighters on a new anti-asbestos campaign. In a continued push toward a national ban of the toxic mineral, the organizations have created a 120 foot high and 84 foot wide billboard in New York City’s Times Square.
A firefighter in full gear is the focal point of the advertisement. Written on the picture are the words: “Firefighters Face Risk.” Under that in large red letters it reads: “Ban Asbestos Now.”
The message is expected to make 1.5 million impressions a day and will be seen 4 times every hour for 1...
Source: Asbestos and Mesothelioma News - February 6, 2024 Category: Environmental Health Authors: Travis Rodgers Tags: Asbestos (general) Asbestos Exposure Awareness/Advocacy Mesothelioma Support/Support Groups/Organizations Source Type: news
Progress in Early Cancer Diagnosis; Breast Cancer in Younger Women; Diet and Cancer
(MedPage Today) -- Artificial intelligence-driven analysis of blood samples showed potential for early diagnosis of ovarian cancer with 93% accuracy. (Georgia Tech, Gynecologic Oncology)
Hologic announced FDA clearance of a digital cytology system... (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - February 2, 2024 Category: Hematology Source Type: news
Jewish People In England To Get Free Genetic Test For Cancer
People with Jewish ancestry are more likely to carry an altered gene that increases the risk of breast, prostate, ovarian and pancreatic cancer. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - February 1, 2024 Category: Pharmaceuticals Authors: Katherine Hignett, Senior Contributor Tags: Healthcare /healthcare Innovation /innovation standard Source Type: news
Phase I Trial Improves Mesothelioma Survival More Than 200%
Sellas Life Sciences reports its Phase I clinical trial showed improvement of overall survival in patients with pleural mesothelioma. The study focused on a new potential therapy called GPS (galinpepimut-S), an immunotherapy vaccine.
The trial included 10 patients with relapsed or refractory mesothelioma, nine of whom received at least three doses of GPS. Researchers gave the third dose of GPS alongside the checkpoint inhibitor Opdivo (nivolumab).
President of Sellas, Angelos Stergiou, stated in a press release, “As we had hypothesized in the past, this increase in survival appears to be consistent with long-...
Source: Asbestos and Mesothelioma News - January 31, 2024 Category: Environmental Health Authors: Travis Rodgers Tags: Clinical Trials/Research/Emerging Treatments Immunotherapy Mesothelioma Source Type: news
Early Mesothelioma Vaccine Testing Shows Survival Gains
Sellas Life Sciences reports its Phase I clinical trial showed improvement of overall survival in patients with pleural mesothelioma. The study focused on a new potential therapy called GPS (galinpepimut-S), an immunotherapy vaccine.
The trial included 10 patients with relapsed or refractory mesothelioma, nine of whom received at least three doses of GPS. Researchers gave the third dose of GPS alongside the checkpoint inhibitor Opdivo (nivolumab).
President of Sellas, Angelos Stergiou, stated in a press release, “As we had hypothesized in the past, this increase in survival appears to be consistent with long-...
Source: Asbestos and Mesothelioma News - January 31, 2024 Category: Environmental Health Authors: Sean Marchese Tags: Clinical Trials/Research/Emerging Treatments Immunotherapy Mesothelioma Source Type: news
Early Mesothelioma Vaccine Testing Shows Promise
Sellas Life Sciences reports its Phase I clinical trial showed improvement of overall survival in patients with pleural mesothelioma. The study focused on a new potential therapy called GPS (galinpepimut-S), an immunotherapy vaccine.
The trial included 10 patients with relapsed or refractory mesothelioma, nine of whom received at least three doses of GPS. Researchers gave the third dose of GPS alongside the checkpoint inhibitor Opdivo (nivolumab).
President of Sellas, Angelos Stergiou, stated in a press release, “As we had hypothesized in the past, this increase in survival appears to be consistent with long-...
Source: Asbestos and Mesothelioma News - January 31, 2024 Category: Environmental Health Authors: Sean Marchese Tags: Clinical Trials/Research/Emerging Treatments Immunotherapy Mesothelioma Source Type: news
New Strategy Improves Early-Stage Ovarian Cancer Detection New Strategy Improves Early-Stage Ovarian Cancer Detection
A new screening approach demonstrated positive predictive value of 50% for ovarian cancer and 74% for any cancer, with most cancers detected in stages I and II.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - January 25, 2024 Category: Cancer & Oncology Tags: Hematology-Oncology Source Type: news
Two-Stage Screening Strategy for Ovarian Cancer Continues to Show Progress
(MedPage Today) -- A two-stage ovarian cancer screening strategy substantially improved early-stage detection among average-risk postmenopausal women, according to long-term follow-up from a large prospective study.
Combining serial CA125 values... (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - January 25, 2024 Category: Hematology Source Type: news
J & J to Pay $700 Million to Settle Talc Baby Powder Investigation
Johnson & Johnson’s $700 million deal will resolve a talcum powder investigation a group of 43 State Attorneys Generals launched. J&J is accused of not warning people about potential health risks linked to its talc-based baby powder.
This latest settlement won’t resolve thousands of other lawsuits that claim the company’s talc-based products cause cancer. In total 50,000 claims have been filed against J&J, the majority of which claim the company’s talc caused ovarian cancer. J&J maintains that its products don’t cause cancer.
“I view this settlement as part of J&J’s overall str...
Source: Asbestos and Mesothelioma News - January 24, 2024 Category: Environmental Health Authors: Daniel Mojica Tags: Asbestos (general) Asbestos Exposure johnson Litigation Mesothelioma Settlement Source Type: news
Menopause Is Finally Going Mainstream
Kathryn Clancy wrote an entire book about menstrual cycles. But even she was surprised by some of the pre-menopausal symptoms she recently began to experience at age 44.
“A lot of things that have to do with my uterus, ovaries, and breasts, I have been massively underprepared for as a Ph.D.-level expert in this field,” says Clancy, a professor at the University of Illinois Urbana-Champaign. “That should tell you how even more underprepared most people are.”
[time-brightcove not-tgx=”true”]
Most people who menstruate will experience symptoms including hot flashes, brain fog, and ch...
Source: TIME: Health - January 23, 2024 Category: Consumer Health News Authors: Jamie Ducharme Tags: Uncategorized healthscienceclimate Source Type: news
